News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
735,041 Results
Type
Article (44180)
Company Profile (308)
Press Release (690552)
Multimedia
Podcasts (95)
Webinars (15)
Section
Business (214666)
Career Advice (2145)
Deals (37215)
Drug Delivery (111)
Drug Development (83874)
Employer Resources (177)
FDA (16814)
Job Trends (15735)
News (361937)
Policy (34381)
Tag
Academia (2709)
Accelerated approval (6)
Adcomms (24)
Allergies (97)
Alliances (53612)
ALS (108)
Alzheimer's disease (1464)
Antibody-drug conjugate (ADC) (173)
Approvals (16798)
Artificial intelligence (322)
Autoimmune disease (29)
Automation (18)
Bankruptcy (376)
Best Places to Work (12025)
BIOSECURE Act (20)
Biosimilars (119)
Biotechnology (198)
Bladder cancer (89)
Brain cancer (35)
Breast cancer (358)
Cancer (2778)
Cardiovascular disease (215)
Career advice (1793)
Career pathing (31)
CAR-T (187)
CDC (28)
Cell therapy (505)
Cervical cancer (21)
Clinical research (68650)
Collaboration (1017)
Company closure (3)
Compensation (634)
Complete response letters (25)
COVID-19 (2739)
CRISPR (63)
C-suite (300)
Cystic fibrosis (113)
Data (2806)
Decentralized trials (2)
Denatured (37)
Depression (59)
Diabetes (303)
Diagnostics (6602)
Digital health (22)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (139)
Drug pricing (134)
Drug shortages (30)
Duchenne muscular dystrophy (115)
Earnings (89588)
Editorial (43)
Employer branding (21)
Employer resources (152)
Events (118726)
Executive appointments (850)
FDA (18364)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (893)
Gene editing (136)
Generative AI (28)
Gene therapy (384)
GLP-1 (809)
Government (4693)
Grass and pollen (5)
Guidances (179)
Healthcare (19524)
Huntington's disease (28)
IgA nephropathy (36)
Immunology and inflammation (156)
Immuno-oncology (7)
Indications (36)
Infectious disease (2898)
Inflammatory bowel disease (153)
Inflation Reduction Act (11)
Influenza (59)
Intellectual property (112)
Interviews (334)
IPO (17023)
IRA (51)
Job creations (4120)
Job search strategy (1523)
Kidney cancer (13)
Labor market (49)
Layoffs (523)
Leadership (20)
Legal (8486)
Liver cancer (80)
Lung cancer (391)
Lymphoma (195)
Machine learning (9)
Management (60)
Manufacturing (384)
MASH (88)
Medical device (13758)
Medtech (13763)
Mergers & acquisitions (20839)
Metabolic disorders (804)
Multiple sclerosis (94)
NASH (19)
Neurodegenerative disease (124)
Neuropsychiatric disorders (35)
Neuroscience (2132)
NextGen: Class of 2025 (6916)
Non-profit (4728)
Now hiring (45)
Obesity (423)
Opinion (249)
Ovarian cancer (95)
Pain (113)
Pancreatic cancer (108)
Parkinson's disease (179)
Partnered (25)
Patents (285)
Patient recruitment (138)
Peanut (52)
People (60524)
Pharmaceutical (93)
Pharmacy benefit managers (22)
Phase I (21346)
Phase II (30204)
Phase III (22617)
Pipeline (1577)
Policy (192)
Postmarket research (2663)
Preclinical (9097)
Press Release (68)
Prostate cancer (131)
Psychedelics (33)
Radiopharmaceuticals (264)
Rare diseases (465)
Real estate (6412)
Recruiting (67)
Regulatory (23593)
Reports (50)
Research institute (2469)
Resumes & cover letters (368)
Rett syndrome (9)
RNA editing (9)
RSV (48)
Schizophrenia (88)
Series A (155)
Series B (104)
Service/supplier (13)
Sickle cell disease (62)
Special edition (19)
Spinal muscular atrophy (153)
Sponsored (34)
Startups (3886)
State (2)
Stomach cancer (15)
Supply chain (74)
Tariffs (61)
The Weekly (56)
Vaccines (792)
Venture capitalists (49)
Weight loss (274)
Women's health (44)
Worklife (16)
Date
Today (67)
Last 7 days (517)
Last 30 days (2423)
Last 365 days (32693)
2025 (15453)
2024 (36308)
2023 (41214)
2022 (52459)
2021 (57008)
2020 (55650)
2019 (48608)
2018 (36731)
2017 (33764)
2016 (33350)
2015 (39355)
2014 (33114)
2013 (28151)
2012 (30189)
2011 (30943)
2010 (28910)
Location
Africa (808)
Alabama (64)
Alaska (7)
Arizona (251)
Arkansas (14)
Asia (42042)
Australia (6740)
California (7194)
Canada (2270)
China (653)
Colorado (307)
Connecticut (308)
Delaware (182)
Europe (90756)
Florida (1079)
Georgia (239)
Idaho (63)
Illinois (633)
India (28)
Indiana (358)
Iowa (15)
Japan (215)
Kansas (109)
Kentucky (26)
Louisiana (14)
Maine (73)
Maryland (1006)
Massachusetts (5386)
Michigan (241)
Minnesota (438)
Mississippi (3)
Missouri (87)
Montana (29)
Nebraska (25)
Nevada (78)
New Hampshire (67)
New Jersey (1991)
New Mexico (30)
New York (2024)
North Carolina (1118)
North Dakota (10)
Northern California (3160)
Ohio (231)
Oklahoma (15)
Oregon (39)
Pennsylvania (1563)
Puerto Rico (16)
Rhode Island (36)
South America (1195)
South Carolina (34)
South Dakota (1)
Southern California (2682)
Tennessee (121)
Texas (1073)
United States (26875)
Utah (213)
Virginia (185)
Washington D.C. (72)
Washington State (625)
West Virginia (4)
Wisconsin (68)
735,041 Results for "catalyst pharmaceutical partners inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025
April 30, 2025
·
2 min read
Press Releases
Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer
June 3, 2025
·
4 min read
Press Releases
Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025
April 23, 2025
·
2 min read
Press Releases
Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update
May 8, 2025
·
13 min read
Santhera’s Partner Catalyst Pharmaceuticals Launches AGAMREE® (Vamorolone) in the United States
Santhera Pharmaceuticals is pleased to note the launch of AGAMREE® for the treatment of Duchenne muscular dystrophy in the United States by Catalyst Pharmaceuticals, Inc., the Company’s commercialization partner for North America.
March 14, 2024
·
5 min read
Press Releases
Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals
April 9, 2025
·
5 min read
Press Releases
Health Catalyst to Participate in Upcoming Investor Conferences
May 20, 2025
·
1 min read
Press Releases
Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference
March 4, 2025
·
2 min read
Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024
Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX) today announced that Richard J. Daly, President and CEO of Catalyst, along with other members of Catalyst’s management team, will participate at the upcoming Jefferies Global Healthcare Conference 2024 on Wednesday, June 5, 2024, in New York.
May 28, 2024
·
3 min read
Press Releases
Tagomics Awarded £860k Innovate UK Biomedical Catalyst Grant for Detection of Colorectal Cancer
June 11, 2025
·
2 min read
1 of 73,505
Next
